Solubilized CoQ-10 and carnitine

Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S455000, C424S451000, C514S725000

Reexamination Certificate

active

11206718

ABSTRACT:
The present invention is directed to compositions and methods of delivery of CoQ-10 and an amino acid solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 and the amino acid, such as carnitine, i.e., carnitine tartrate, in formulations, such as soft gel capsules.

REFERENCES:
patent: 4599232 (1986-07-01), Bertelli
patent: 4824669 (1989-04-01), Folkers et al.
patent: 5310578 (1994-05-01), Thurn-Muller et al.
patent: 5378461 (1995-01-01), Neigut
patent: 5500416 (1996-03-01), Miyazawa et al.
patent: 5626849 (1997-05-01), Hastings et al.
patent: 5637316 (1997-06-01), Ribier et al.
patent: 5670320 (1997-09-01), Wallace et al.
patent: 5686491 (1997-11-01), Sherwood
patent: 5756291 (1998-05-01), Griffin et al.
patent: 5843476 (1998-12-01), Ribier et al.
patent: 5889062 (1999-03-01), Hoppe et al.
patent: 5912272 (1999-06-01), Hoppe et al.
patent: 5948443 (1999-09-01), Riley et al.
patent: 5976568 (1999-11-01), Riley
patent: 5977162 (1999-11-01), Seidman
patent: 6020383 (2000-02-01), Stone et al.
patent: 6033678 (2000-03-01), Lorenzen
patent: 6048846 (2000-04-01), Cochran
patent: 6048886 (2000-04-01), Neigut
patent: 6054136 (2000-04-01), Farah et al.
patent: 6063432 (2000-05-01), Maxwell et al.
patent: 6069167 (2000-05-01), Sokol
patent: 6080788 (2000-06-01), Sole et al.
patent: 6203818 (2001-03-01), Vester
patent: 6232346 (2001-05-01), Sole et al.
patent: 6261575 (2001-07-01), Hoppe et al.
patent: 6300361 (2001-10-01), Chopra
patent: 6335361 (2002-01-01), Hamilton
patent: 6342526 (2002-01-01), Vervuert et al.
patent: 6426362 (2002-07-01), Miller et al.
patent: 6428779 (2002-08-01), Sauermann et al.
patent: 6441050 (2002-08-01), Chopra
patent: 6455589 (2002-09-01), Ames et al.
patent: 6469024 (2002-10-01), Tino et al.
patent: 6472378 (2002-10-01), von Borstel
patent: 6479069 (2002-11-01), Hamilton
patent: 6503506 (2003-01-01), Germano
patent: 6503523 (2003-01-01), Hoppe et al.
patent: 6506915 (2003-01-01), West
patent: 6528042 (2003-03-01), Brown et al.
patent: 6545184 (2003-04-01), Lipshutz
patent: 6562869 (2003-05-01), Hamilton et al.
patent: 6579854 (2003-06-01), Mitchell et al.
patent: 6616942 (2003-09-01), Udel
patent: 2003/0147927 (2003-08-01), Khan et al.
patent: 2003/0232095 (2003-12-01), Garti et al.
patent: 2004/0001874 (2004-01-01), Davidson et al.
patent: 2004/0047922 (2004-03-01), Elstner
patent: 2005/0025756 (2005-02-01), Erwin
patent: 3512054 (1986-10-01), None
patent: 0 888 774 (1999-01-01), None
patent: 57-042616 (1982-03-01), None
patent: WO8803015 (1988-05-01), None
patent: WO98/40086 (1998-09-01), None
patent: WO 02/09685 (2002-02-01), None
patent: WO 200209685 (2002-02-01), None
patent: WO 03/105607 (2003-12-01), None
R. Chopra et al., “A New Coenzyme Q10 Preparation with Enhanced Bioavailability”, FASEB Journal, 11 3), pp. A586, 1997, Abstract.
M. Weis, et al., “Bioavailability of Four Oral Coenzyme Q10 Formulations in Healthy Volunteers”, Molec. Aspects. Med., vol. 15, (Supplement) pp. s273-s280,1994.
http://www.pformulate.com/pformsoftgel.htm.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Solubilized CoQ-10 and carnitine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Solubilized CoQ-10 and carnitine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solubilized CoQ-10 and carnitine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3760546

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.